Your browser doesn't support javascript.
loading
4-Cyclo-propyl-1-(6'-de-oxy-1',2'-O-iso-propyl-idene-α-d-gluco-furanos-yl)-1H-1,2,3-triazole.
Zhang, Qiurong; He, Peng; Zhou, Guangqiang; Yu, Kang; Liu, Hongmin.
  • Zhang Q; New Drug Reseach & Development Center, Zhengzhou Univresity, Zhengzhou 450001, People's Republic of China.
  • He P; New Drug Reseach & Development Center, Zhengzhou Univresity, Zhengzhou 450001, People's Republic of China.
  • Zhou G; New Drug Reseach & Development Center, Zhengzhou Univresity, Zhengzhou 450001, People's Republic of China.
  • Yu K; New Drug Reseach & Development Center, Zhengzhou Univresity, Zhengzhou 450001, People's Republic of China.
  • Liu H; New Drug Reseach & Development Center, Zhengzhou Univresity, Zhengzhou 450001, People's Republic of China.
Article en En | MEDLINE | ID: mdl-24427028
ABSTRACT
In the title compound, C14H21N3O5, the tetra-hydro-furan ring adopts an envelope conformation with the C atom bearing the substituent as the flap. The penta-furan-ose ring adopts a twisted conformation about the C-C bond fusing the rings. The dihedral angle between these rings (all atoms), which are cis fused, is 72.89 (14)°. The cyclo-propane ring is disordered over two orientations in a 0.576 (5)0.424 (5) ratio; the dihedral angles subtended to the triazole ring are 53.3 (11) and 46.6 (9)°, respectively. In the crystal, the mol-ecules are linked by O-H⋯N and O-H⋯O hydrogen bonds, generating (001) sheets. A weak C-H⋯O inter-action also occurs.